Drugs / HCP1007
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01929070 | Feb → Mar 2013 | — | Hanmi Pharmaceutical Company Limited | Completed | No outcome recorded |
| Phase 1 | NCT01548157 | Mar 2012 | — | Hanmi Pharmaceutical Company Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HCP1007 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01929070 ↗ |
| Route | Oral | “after oral administration of HCP1007 capsules and Rosuvastatin plus Omega-3” NCT01548157 ↗ |